These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 38339075)

  • 21. Pathogenesis of myocarditis and dilated cardiomyopathy.
    Cihakova D; Rose NR
    Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmunity in coxsackievirus B3 induced myocarditis.
    Huber SA
    Autoimmunity; 2006 Feb; 39(1):55-61. PubMed ID: 16455582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis.
    Meyer IS; Goetzke CC; Kespohl M; Sauter M; Heuser A; Eckstein V; Vornlocher HP; Anderson DG; Haas J; Meder B; Katus HA; Klingel K; Beling A; Leuschner F
    Front Immunol; 2018; 9():2303. PubMed ID: 30349538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergism between adriamycin and coxsackie virus group B type 3 (CVB3) in induction of myocardial injury: potential role for gamma/delta TcR+ T lymphocytes in pathogenesis.
    Moraska A; Huber SA
    Clin Immunol Immunopathol; 1993 Aug; 68(2):124-8. PubMed ID: 8395357
    [No Abstract]   [Full Text] [Related]  

  • 26. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group.
    Roivainen M; Knip M; Hyöty H; Kulmala P; Hiltunen M; Vähäsalo P; Hovi T; Akerblom HK
    J Med Virol; 1998 Sep; 56(1):74-8. PubMed ID: 9700636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis.
    Lawson CM
    Cell Mol Life Sci; 2000 Apr; 57(4):552-60. PubMed ID: 11130455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential clinical implications of molecular mimicry-induced autoimmunity.
    Suliman BA
    Immun Inflamm Dis; 2024 Feb; 12(2):e1178. PubMed ID: 38415936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
    Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
    J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
    Sané F; Moumna I; Hober D
    Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmunity in myocarditis: models and mechanisms.
    Rose NR; Herskowitz A; Neumann DA
    Clin Immunol Immunopathol; 1993 Aug; 68(2):95-9. PubMed ID: 8395364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of viruses in the etiopathogenesis of diabetes mellitus.
    Strycharz M; Bartecka K; Polz-Dacewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):257-60. PubMed ID: 16145992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elution of autoantibodies from the hearts of coxsackievirus-infected mice.
    Neumann DA; Lane JR; LaFond-Walker A; Allen GS; Frondoza C; Herskowitz A; Rose NR
    Eur Heart J; 1991 Aug; 12 Suppl D():113-6. PubMed ID: 1655441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis.
    Neumann DA; Rose NR; Ansari AA; Herskowitz A
    J Immunol; 1994 Jan; 152(1):343-50. PubMed ID: 8254202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic prevalence of coxsackievirus group B in Greece.
    Mavrouli MD; Spanakis N; Levidiotou S; Politi C; Alexiou S; Tseliou P; Hatzitaki M; Foundouli K; Tsakris A; Legakis NJ; Routsias JG
    Viral Immunol; 2007; 20(1):11-8. PubMed ID: 17425417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited heterogeneity of autoantigens and T cells in autoimmune diseases?
    Acha-Orbea H
    Res Immunol; 1991; 142(5-6):487-90. PubMed ID: 1754724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coxsackieviruses and diabetes.
    Solimena M; De Camilli P
    Nat Med; 1995 Jan; 1(1):25-6. PubMed ID: 7584948
    [No Abstract]   [Full Text] [Related]  

  • 38. T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vbeta usage without superantigenic activity.
    Varela-Calvino R; Sgarbi G; Wedderburn LR; Dayan CM; Tremble J; Peakman M
    J Immunol; 2001 Sep; 167(6):3513-20. PubMed ID: 11544345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of microbial infections and the immune response to cardiac antigens.
    Penninger JM; Bachmaier K
    J Infect Dis; 2000 Jun; 181 Suppl 3():S498-504. PubMed ID: 10839747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease.
    Cunningham MW
    Front Biosci; 2003 May; 8():s533-43. PubMed ID: 12700052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.